PR94825

PHILADELPHIA, Mar. 8, 2022 /PRNewswire=KYODO JBN/--

--Alongside brand refresh, leading clinical trial technology company announces

eConsent and eCOA offerings to better support the patient clinical trial

journey.

Suvoda (

https://c212.net/c/link/?t=0&l=en&o=3462285-1&h=1410908613&u=https%3A%2F%2Fwww.suvoda.com%2F%3Futm_source%3Dpress-release%26utm_medium%3Dweb%26utm_content%3Dsuvoda-brand-refresh&a=Suvoda

)LLC today launched a refreshed brand, to better reflect its leadership

position as a global clinical trial technology company that specializes in

highly complex studies, such as oncology, central nervous system and rare

disease. The updated brand comes with a new tagline, Trial wisely, embodying

Suvoda's expertise in supporting and empowering pharmaceutical and

biotechnology companies to take command over the ever-growing operational

complexities of life-sustaining studies. After a standout year in 2021 and

having supported nearly 1,000 trials across 65 countries since its founding,

the company recently expanded beyond its flagship IRT product. Suvoda announced

the release of its eConsent and eCOA solutions—now in early adopter

phase—marking a critical step in Suvoda's path to streamline complex clinical

trials.

Logo - https://mma.prnewswire.com/media/1759317/Suvoda_Logo.jpg

"Clinical trials are in the midst of a major shift in complexity and

patient-centricity, forcing sponsors and CROs to adapt quickly," said Jagath

Wanninayake, CEO of Suvoda. "Now more than ever, clinical trials require both

urgency and rigor—Suvoda specializes in both. Our new brand reflects Suvoda's

journey and clarifies our purpose as a trusted partner in managing these

operational complexities. With an expanded solution set of patient-centric

offerings, we are ideally positioned to support the next generation of clinical

trials."

The day-to-day work lives of clinical trial professionals have become ever more

challenging as they deal with the realities of the COVID-19 pandemic, trends

around patient centricity and decentralization. Additionally, due to medical

advances, trials in areas like oncology, CNS and rare disease have unique

challenges that are creating greater logistical complexity.

Building on the company's extensive experience fine-tuning management of these

complexities through its precision-built products, rigorously defined

processes, and exceptionally prepared people, Suvoda is applying the same

standards of excellence to its new eConsent and eCOA offerings.

What unites these products, which will operate seamlessly on a single platform,

is their ability to manage time sensitive, mission critical moments in

life-sustaining trials. This product expansion provides trial managers greater

visibility into—and control of—the patient journey, while simultaneously

simplifying and enhancing the patient experience.

"At Suvoda, we have an intense focus on getting things right for our

customers," said Elena Filimonova, chief marketing officer at Suvoda. "The most

rewarding part of the rebranding process was hearing from customers, employees,

and industry influencers that what we do and how we do it is exceptional. We

are excited to tell the Suvoda story, knowing that our position is authentic

and supportable, and that we are poised to deliver on a global scale."

As part of the brand launch, Suvoda is unveiling a new logo—a streamlined word

mark whose horizontal flow reflects the company's support of the patient

journey across the full lifespan of a trial. The brand is supported by an

updated color palette and look and feel dominated by close-up photography that

keeps the focus on those whom Suvoda serves—clinicians and patients. As part of

today's brand reveal, the company launched a new website. To experience the new

Suvoda, visit www.suvoda.com.

About Suvoda

Suvoda is a global clinical trial technology company that specializes in highly

complex, life-sustaining studies in therapeutic areas like oncology, central

nervous system, and rare disease. Founded in 2013 by experts in eClinical

technologies, Suvoda empowers clinical trial professionals to manage the most

urgent moments in the most urgent trials through its IRT, eConsent, and eCOA

solutions delivered on a single platform. Headquartered outside Philadelphia,

Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest,

Romania and Tokyo, Japan. The company consistently boasts a customer

satisfaction index of 9 out of 10, an NPS score of 70 in its annual surveys,

and has been selected by trial sponsors and CROs to support nearly 1000 trials

across 65 countries. To learn more, visit: suvoda.com (

https://c212.net/c/link/?t=0&l=en&o=3462285-1&h=2455195697&u=https%3A%2F%2Fwww.suvoda.com%2F%3Futm_source%3Dpress-release%26utm_medium%3Dweb%26utm_content%3Dsuvoda-brand-refresh&a=suvoda.com

). Follow Suvoda on Twitter (

https://c212.net/c/link/?t=0&l=en&o=3462285-1&h=756654024&u=https%3A%2F%2Ftwitter.com%2FSuvodaIRT&a=Twitter

) and LinkedIn (

https://c212.net/c/link/?t=0&l=en&o=3462285-1&h=2386977751&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fsuvoda%2Fmycompany%2F&a=LinkedIn

).

SOURCE: Suvoda LLC

CONTACT: Mary Conway, Clyde Group, Mary.Conway@ClydeGroup.com